[Percutaneous transhepatic litholysis--indications, results, risks].
A total of 170 patients with symptomatic cholesterol stones in the gallbladder were scheduled for percutaneous transhepatic dissolution with MTBE. Puncture was successful in 167/170 patients; stones dissolved in 161/167. The treatment of solitary stones averaged 3.9 hours, whereas multiple stones required 9.6 hours. The mean hospitalisation time was 3.6 days. After litholysis 1/3 of the patients had sludge in the gallbladder; most of them were free of residue after treatment for 3 months with UDC/CDC. Complications included hemobilia in 2/167, perforation in 1/167 and bile leakage in 7/167 (5 had surgery).
Hellstern
A
A
Medizinische Universitätsklinik Frankfurt.
Leuschner
U
U
Gatzen
M
M
D002635:Chenodeoxycholic Acid / Q000008:administration & dosage; D002769:Cholelithiasis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D004987:Ethers / Q000008:administration & dosage*; D006801:Humans; D008738:Methyl Ethers; D007507:Therapeutic Irrigation / Q000295:instrumentation*; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage
D004987:Ethers; D008738:Methyl Ethers; D002635:Chenodeoxycholic Acid; C043243:methyl tert-butyl ether; D014580:Ursodeoxycholic Acid